Class & Mechanism — LL-37 is a human cathelicidin antimicrobial peptide with broad-spectrum antimicrobial activity, immunomodulatory functions, and a role in wound healing and inflammation.
Research-documented benefits — [3] Reduced S. aureus infection; [4] Key functions in protection against bacterial challenge; [5] Chemoattractant properties; [6] Participation in innate immunity.
General-knowledge benefits — LL-37 is highly expressed in psoriatic skin and rosacea, and its deficiency is associated with increased susceptibility to infections.
Typical injectable protocol — Research-only, experimental. Dosing information is not available in the provided excerpts.
Key risks / contraindications — No specific risks mentioned in the provided excerpts.
Bottom line — LL-37 is a crucial component of the innate immune system with potential therapeutic applications, but its use in humans requires further research.
References
- Antimicrobial Peptides and Human Disease
- Antimicrobial Peptides_ Basics for Clinical Application
- Antimicrobial peptides and the skin immune defense system
- Antimicrobial peptides from plants with potential against multidrug-resistant bacteria
- Boundless Upgrade Your Brain, Optimize Your Body and Defy — Ben Greenfield
- Click Chemistry_ A Universal Ligation Strategy
- GHK Peptide as a Natural Modulator of Multiple Cellular — Loren Pickart
- Handbook of Biologically Active Peptides
- Kosmetik für Ärzte und Apotheker
- Life Force
- Living a Fully Optimized Life
- Mechanisms of Photoaging and Cutaneous Photocarcinogenesis
- Novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157. Vascular recruitment and gastrointestinal tract
- Pentadecapeptide BPC 157 (PL 14736) improves ligament — Tomislav Cerovecki
- Peptide Protocols Volume One — William A Seeds MD
- Peptide therapy with pentadecapeptide BPC 157 in traumatic — Gjurasin, Miroslav
- Rook's Textbook of Dermatology
- The effect of pentadecapeptide BPC 157, H-blockers — Predrag Sikiric
- The pharmacological properties of the novel peptide BPC 157 — P Sikiric（Affiliation Department of Pharmacology, Medical
- Traumatic brain injury in mice and pentadecapeptide BPC 157 — Mario Tudor